FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
scientific program, Monday, 26 November 2007MP-02Moderated Poster Session14.30 - 16.00 Room 3Pharmacology, hormonesChairpersons: Emre Akkus, TurkeyGiovanni Corona, ItalyMP-02-086 Intravenous administration <strong>of</strong>7-hydroxy-2-(di-N-propylamino) tetralininduces sexual responses inanaes<strong>the</strong>tised male ratsMagali Peeters, FranceP. Clement, J. Bernabe, S. Caisey,F. Giuliano (Presenter)MP-02-087 FK506 and erectile functionpreservation in <strong>the</strong> cavernousnerve injury model: Optimal dosingand timingAlexander Müller, SwitzerlandJ. Donohue, R. Tal, K. Kobylarz,T. Sulser, P. Scardino, J. MulhallMP-02-088 Bilateral cavernous neurotomyinduces hypogonadotropic hypogonadismin rat: Effect <strong>of</strong> testosteroneand tadalafil supplementationSandra Filippi, ItalyA. Morelli, L. Vignozzi, R. Mancina,E. Silvestrini, A. Chavalmane, M. Marini,G. B. Vannelli, M. MaggiMP-02-089 Cyclic AMP-dependent proteinkinase-I alpha is involved in <strong>the</strong>relaxation <strong>of</strong> human cavernousarteries exerted by PDE5 inhibitorsEginhard Waldkirch, GermanyS. Ueckert, J. Sonnenberg, F. Imkamp,M. Seidler, M. Sohn, U. Jonas,J. E. Sonnenberg, P. HedlundMP-02-090MP-02-091Mechanisms <strong>of</strong> <strong>the</strong> relaxant effect<strong>of</strong> vardenafil in rat penile arteriesAna Sanchez, SpainN. Villaba, M. Monroy, A. GarciaSacristan, M. Hernandez, D. PrietoValidation <strong>of</strong> electronic stopwatchmeasurements <strong>of</strong> erection durationagainst responses to <strong>the</strong> sexualencounter pr<strong>of</strong>ile and internationalindex <strong>of</strong> erectile functionJames Shaw, USAG. Reardon, D. Sandor, R. Rosen,D. FergusonMP-02-092MP-02-093MP-02-094MP-02-095MP-02-096MP-02-097A comparison <strong>of</strong> vardenafil andsildenafil: Efficacy among men wi<strong>the</strong>rectile dysfunction and relatedcomorbiditiesEusebio Rubio-Aurioles, MexicoH. Porst, I. Eardley, I. GoldsteinRelationship between successfulsexual intercourse and <strong>the</strong> erectionhardness scoreJohn Mulhall, USAI. Goldstein, A. Bushmakin, J. Cappelleri,K. Hvidsten, T. SymondsVardenafil treatment <strong>of</strong> erectiledysfunction in depressive and nondepressivemen (VALOR study)– pilot results from 958 PolishpatientsBarbara Darewicz, PolandJ. Kudelski, M. Chlabicz, M. Wronka,B. Kozlowska-BoszkoA comparison <strong>of</strong> vardenafil andsildenafil: Treatment preferenceand satisfaction among men withED and related comorbiditiesEusebio Rubio-Aurioles, MexicoH. Porst, I. Eardley, I. GoldsteinA double-blind, randomized, placebo-controlled,crossover study toeva-luate changes in retinal functionin healthy males after multiple doses<strong>of</strong> <strong>the</strong> phosphodiesterase type-5inhibitor vardenafilAlexander Brucker, USAD. Scheraga (Presenter), S. Boxley, J. Dupont,J. Gausas, M. Al-BannaTadalafil 5 mg or sildenafil citrate50 mg administered daily for upto 6 months does not affect visualsafetyWilliam H. Cordell, USAR. K. Maturi, T. M. Costigan, M. F. Marmor,R. G. Weleber, S. G. Coupland,R. P. Danis, J. W. McGettigan, Jr,A. N. Antoszyk, S. Klise, G. D. Sides,R. K. Maturi (Presenter)27
Change language